Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers
E Vilar-Gomez, N Chalasani - Journal of hepatology, 2018 - Elsevier
The correct identification of patients at increased risk of non-alcoholic steatohepatitis
(NASH) and advanced fibrosis is a critical step in the assessment of non-alcoholic fatty liver …
(NASH) and advanced fibrosis is a critical step in the assessment of non-alcoholic fatty liver …
Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers
E Vilar-Gomez, N Chalasani - Journal of hepatology, 2018 - pubmed.ncbi.nlm.nih.gov
The correct identification of patients at increased risk of non-alcoholic steatohepatitis
(NASH) and advanced fibrosis is a critical step in the assessment of non-alcoholic fatty liver …
(NASH) and advanced fibrosis is a critical step in the assessment of non-alcoholic fatty liver …
[引用][C] Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers
E Vilar-Gomez, N Chalasani - Journal of Hepatology, 2018 - cir.nii.ac.jp
Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and
blood-based biomarkers | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
blood-based biomarkers | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers
E Vilar-Gomez, N Chalasani - Journal of Hepatology, 2018 - journal-of-hepatology.eu
The correct identification of patients at increased risk of non-alcoholic steatohepatitis
(NASH) and advanced fibrosis is a critical step in the assessment of non-alcoholic fatty liver …
(NASH) and advanced fibrosis is a critical step in the assessment of non-alcoholic fatty liver …
Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers.
E Vilar-Gomez, N Chalasani - Journal of Hepatology, 2017 - europepmc.org
The correct identification of patients at increased risk of non-alcoholic steatohepatitis
(NASH) and advanced fibrosis is a critical step in the assessment of non-alcoholic fatty liver …
(NASH) and advanced fibrosis is a critical step in the assessment of non-alcoholic fatty liver …
Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers
E Vilar-Gomez, N Chalasani - Journal of Hepatology, 2018 - journal-of-hepatology.eu
The correct identification of patients at increased risk of non-alcoholic steatohepatitis
(NASH) and advanced fibrosis is a critical step in the assessment of non-alcoholic fatty liver …
(NASH) and advanced fibrosis is a critical step in the assessment of non-alcoholic fatty liver …